FEB 26

AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan


Conference CFP




  26 Feb 2019 through 28 Feb 2019

CFP Deadline:

  25 Feb 2019


  Urayasu-shi, Japan

Website URL:


Sponsoring organization:

  KNect365 Life Sciences


  Education / Legal / Other > Education

Cloud tags:

Event description:

Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo. AsiaTIDES 2019 keynote presentation lineup: 1) The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues - Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S 2) New Strategies and Technologies in Oligonucleotide Therapeutic Development - Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals 3) The Chemistry behind Approved Oligonucleotide Therapeutics - Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc. 4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics - Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences URLs: Tickets https://go.evvnt.com/355503-2?pid=4868 Brochure https://go.evvnt.com/355503-3?pid=4868 Prices: Conference Pass + Pre-Conference Workshop: USD 3023.0 Conference Pass: USD 2375.0 Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences Time: 9:00 am - 5:00 pm

Posting date:

30 January 2019
views | 1 subscribers | Be the first to rate this event


Not-featured (How do I make my event featured?)